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Introduction. Antioxidant properties of resveratrol have been intensively studied for the last years, both in vivo and in vitro.
Its bioavailability after an oral dose is very low and therefore it is very important to make sure that plasma concentrations
of free resveratrol are sufficient enough to be active as antioxidant. Aims. In the present study, using nutritionally relevant
concentrations of resveratrol, we aim to confirm its antioxidant capacity on reducing peroxide levels and look for the molecular
pathway involved in this antioxidant effect.Methods.We used mammary gland tumor cells (MCF-7), which were pretreated with
different concentrations of resveratrol for 48 h, and/or a PTEN inhibitor (bpV: bipy). Hydrogen peroxide levels were determined by
fluorimetry, PTEN levels and Akt phosphorylation by Western Blotting, and mRNA expression of antioxidant genes by real-time
reverse transcriptase-polymerase chain reaction (RT-PCR). Results.Resveratrol treatment for 48 h lowered peroxide levels inMCF-
7, even at low nutritional concentrations (1 nM). This effect was mediated by the activation of PTEN/Akt pathway, which resulted
in an upregulation of catalase and MnSOD mRNA levels. Conclusion. Resveratrol acts as an antioxidant at nutritionally relevant
concentrations by inducing the expression of antioxidant enzymes, through a mechanism involving PTEN/Akt signaling pathway.
1. Introduction
In the last two decades, life expectancy at birth has increased
by 5–10 years [1]. As a consequence, the population is growing
older and therefore there is increasing interest in how to
face age-related problems. Oxidative damage to biomolecules
caused by reactive oxygen species (ROS) plays an important
role in the aging process, as stated in the free radical theory
of aging [2].This occurs when an imbalance between the pro-
duction of free radicals and the ability of the natural antiox-
idant defenses to scavenge them exists. We have previously
suggested the possibility that the intake of nonvitamin antiox-
idants such as nutrients or natural compounds may be effec-
tive in increasing antioxidant defenses, by upregulating the
activity of antioxidant enzymes, which are normally present
in cells [3]. One of these plausible antioxidants is resveratrol
(trans-3,5,4󸀠-trihydroxystilbene), a natural polyphenol found
in many plants and fruits, such as blueberries, blackberries,
peanuts, and grapes, and specially in red wine, the main
source in the human diet [4]. Resveratrol properties as an
antioxidant have been intensively studied for the last years
[5–10], both in vivo and in vitro, but the mechanism involved
remains unclear. Moreover, its bioavailability after an oral
dose is very low. In fact, plasma concentrations of free trans-
resveratrol after ingestion of 600mL of red wine [11] or an
oral dose of 25mg [12, 13] are extremely low, of the order of
nanomolar or lowmicromolar.Therefore, it is very important
to make sure that those nutritionally relevant low plasma
concentrations of free resveratrol are sufficient enough to be
active as an antioxidant [13, 14].
One of the antioxidant effects attributed to resveratrol is
the ability to protect cells against H
2
O
2
-induced oxidative
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Figure 1: Resveratrol diminishes hydrogen peroxide levels in MCF-
7 cells. Peroxide levels were determined by fluorimetry using
homovanillic acid (see Section 3). Cells were treated with resveratrol
or with estradiol for 48 h. Data are expressed as means + SD for 15
different experiments; ∗𝑃 < 0.05; ∗∗𝑃 < 0.01 versus control.
stress [15, 16]. Furthermore, resveratrol is able to increase
the phosphatase and tensin homolog PTEN [17, 18], a well-
known tumor suppressor that antagonizes the activity of
phosphatidylinositol 3-kinase type I (PI3K), thus leading to
decreased phosphorylated-Akt (P-Akt) levels [19]. Interest-
ingly, it has been recently reported that PTEN is able to
increase energy expenditure and improve organismal sur-
vival independently of its effect on cancer, thus suggesting
that PTEN might have multiple protective functions [20].
We have previously reported that oestradiol and genistein
are able to decrease hydrogen peroxide levels in MCF-7 cells
[21, 22]. Using the same cell line, we report that nutritionally
relevant concentrations of resveratrol are able to decrease
hydrogen peroxide levels not because of its phenolic struc-
ture, but because of the fact that it induces the expression
of antioxidant genes, such as catalase (Cat) and manganese
superoxide dismutase (MnSOD), through a mechanism that
involves phosphatase and tensin homolog (PTEN) and pro-
tein kinase-B (PKB or Akt) signaling pathway. This finding
may be useful to support the idea that, despite having
low bioavailability, it is possible to consider resveratrol as
an important nonvitamin antioxidant and to provide new
insights into the mechanism involved in it.
2. Results
2.1. Nutritional Concentrations of Resveratrol Decrease Hydro-
gen Peroxide Levels in MCF-7 Cells. Figure 1 shows that
resveratrol treatment for 48 h lowers hydrogen peroxide lev-
els, except at the highest dose (1.5𝜇M).These concentrations
are similar to those of free trans-resveratrol found in plasma
after ingestion of 600mL of red wine [11] or an oral dose
of 25mg [12, 13]. Therefore, we find antioxidant effects of
resveratrol at nutritionally relevant concentrations.
2.2. Resveratrol Increases PTEN Protein Levels inMCF-7 Cells.
In order to find out the mechanism by which resveratrol acts
as an antioxidant, we tested if PTEN signaling pathway could
be involved in its antioxidant effect.We found that resveratrol
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Figure 2: Resveratrol activates the PTEN signaling pathway. Levels
of PTEN were measured in cells treated for 48 h with resveratrol
(1 nM). Data are expressed as means + SD for 4 different experi-
ments; ∗𝑃 < 0.05 versus control.
0
2
4
6
8
10
12
14
16
C
on
tro
l
PT
EN
 in
hi
bi
to
r
PT
EN
 in
hi
bi
to
r
p-
A
KT
/tu
bu
lin
 (a
.u
.) 
Tubulin
Control Resveratrol PTEN inhibitor
PTEN 
inhibitor
Pr
ot
ei
n 
sta
nd
ar
d
p-Akt
∗
2
0
nM
Re
sv
er
at
ro
l+
Resveratrol +
Re
sv
er
at
ro
l
1
nM
Figure 3: Resveratrol inactivates the Akt signaling pathway through
PTEN activation inMCF-7 cells. Phospho-Akt levels weremeasured
by Western blotting, after 48 h incubation with resveratrol (1 nM)
alone, potassium bisperoxo (bipyridine) oxovanadate (V) as a PTEN
inhibitor alone (20 nM), or both together. Histograms represent
densitometric measurement of specific bands of phospho-Akt con-
tent using tubulin levels as housekeeping control. Data are expressed
as means + SD for 4 independent experiments; ∗𝑃 < 0.05 versus
control.
treatment for 48 h increased PTEN protein levels in MCF-7
(Figure 2).
2.3. Resveratrol Decreases Akt Phosphorylation via PTEN
Activation in MCF-7 Cells. Figure 3 shows that incubation of
MCF-7 cells with physiological concentrations of resveratrol
(1 nM) for 48 h reduces the phosphorylation of Akt. This
effect can be seen within 5 minutes of incubation and
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Figure 4: Resveratrol upregulates the expression of catalase (a) and MnSOD (b) in MCF-7 cells. Resveratrol (1 nM) increased mRNA levels
of catalase and Mn-superoxide dismutase ( ∗𝑃 < 0.05; ∗∗𝑃 < 0.01 versus control), and these effects were prevented when coincubating with
the PTEN inhibitor (20 nM). Data are expressed as means + SD for 3 different experiments.
reaches the maximum within 48 h. Coincubation with an
inhibitor of PTEN activity (potassium bisperoxo (bipyridine)
oxovanadate (V)) at a dose of 20 nM reverts this effect.
Therefore, the decrease in Akt phosphorylation by resveratrol
is mediated by PTEN activation.
2.4. Resveratrol Upregulates Endogenous Antioxidant Genes
via PTEN Signaling Pathway. Nutritional concentrations of
resveratrol upregulate the expression of catalase (Figure 4(a))
andMnSOD (Figure 4(b)) after 48 h of incubation. However,
this upregulation is prevented when cells are coincubated
with a PTEN inhibitor, suggesting the implication of PTEN
in resveratrol-mediated activation of endogenous antioxidant
gene expression.
2.5. PTEN Mediates the Antioxidant Effect of Resveratrol in
MCF-7 Cells. As stated before, 1 nM resveratrol pretreatment
led to a reduction in intracellular hydrogen peroxide levels.
However, Figure 5 shows how coincubation with a PTEN
inhibitor (20 nM) reverts this antioxidant effect.
3. Materials and Methods
3.1. Cell Culture. Humanmammary gland tumor cells (MCF-
7) were cultured in Iscove’s modified Dulbecco’s medium
(IMDM) without phenol red, supplemented with 10% (v/v)
heat-inactivated fetal bovine serum. Cells were plated in 25
or 75 cm2 culture flasks and maintained at 37∘C with 5% CO
2
in air. All the experiments were performed once cells reached
confluence.
3.2. Treatments. Based on previous experiments of our lab-
oratory [21, 22] and on the literature [17, 18], cells were
treated for 48 h with either DMSO (for the control group),
resveratrol (at concentrations ranging from 1 nM to 1.5 𝜇M),
or resveratrol together with 20 nM bisperoxo (bipyridine)
oxovanadate (V) as PTEN inhibitor [23]. 0.2 nMestradiol was
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Figure 5: Resveratrol diminishes peroxide levels inMCF-7 cells, and
this effect is mediated by the PTEN/Akt signaling pathway. MCF-7
cells were treatedwith resveratrol (1 nM) alone, potassiumbisperoxo
(bipyridine) oxovanadate (V) as a PTEN inhibitor alone (20 nM), or
both together. Data are expressed as means + SD for 4–8 different
experiments; ∗𝑃 < 0.05 versus control.
used as a positive control whenmeasuring hydrogen peroxide
levels [21].
3.3. Determination of Peroxide Levels in MCF-7 Cells. Intra-
cellular levels of hydrogen peroxide were determined by
fluorimetry using a modification of the method described by
Barja [24].
Briefly, cells were washed twice with PBS and then
incubated at 37∘C with a PBS solution containing 0.1mM
homovanillic acid and 6U/mL horseradish peroxidase. The
incubationwas stopped at 5minwith 1mL of cold 2Mglycine
buffer containing 50mM EDTA and 2.2M NaOH. The flu-
orescence of supernatants was measured using 312 nm as an
excitationwavelength and 420 nmas an emissionwavelength.
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The levels of peroxideswere calculated using aH
2
O
2
standard
curve and results were expressed per milligram of protein.
3.4. Immunoblot Analysis of Akt Phosphorylation and PTEN
Protein Expression Levels. After 48 h of pretreatment with
resveratrol, cells were washed twice with cold PBS and lysed
in cold lysis buffer (62.5mM Tris-HCl (pH 6.8 at 25∘C),
2% w/v SDS, 10% v/v glycerol), which was supplemented
with a protease inhibition cocktail (10 𝜇L per 1mL of lysis
buffer) and sodium orthovanadate 200mM (10 𝜇L per 1mL
of lysis buffer) to inactivate proteases and phosphatases.
Immediately after harvesting, aliquots of whole cell lysates
(40 𝜇g, based on previous experiments [21, 22]) were boiled
for 10min, electrophoresed on SDS 10% polyacrylamide gels,
and electroblotted (Bio-Rad) onto a PVDF membrane (Bio-
Rad). Membranes were blocked at room temperature for 1
hour with 0.05 g/mL nonfat milk or BSA 0.05 g/mL in TBS-
0.1% Tween 20 (TBS-T) according to the antibody. After-
wards, membranes were incubated with primary antibodies
against phospho-Akt Ser 473, PTEN (1 : 1000, Cell Signaling
Technologies, Boston, MA, USA), or 𝛼-tubulin as loading
control (1 : 1000, Santa Cruz BioTech USA), overnight at
4∘C. Blots were then washed again three times for 10min
at room temperature and then incubated for 1 h with a
secondary horseradish peroxidase (HRP) linked anti-rabbit
IgG antibody (1 : 2000) (Cell Signaling, Boston, MA, USA).
After washing three times again, membranes were developed
by using the ECL Prime Western Blotting Detection reagent
as specified by the manufacturer (Amersham Pharmacia,
USA). Autoradiographic bands were assessed using a Fuji-
film scanning densitometer (Fujifilm LAS-1000 plus). The
densitometric analysis was performed using Image J 1.34s
software. For comparison between blots, one aliquot of the
same sample was loaded as a standard in each gel to allow
data normalization.
3.5. mRNA Gene Expression. Catalase (Cat) and mangane-
se superoxide dismutase (MnSOD) mRNA expression was
determined by real-time PCR with glyceraldehyde-3P-dehy-
drogenase (GAPDH) as the endogenous control, according to
previously published results [21, 22].
For this purpose, total RNA was isolated from cultures
by extraction with TRIzol Reagent (Invitrogen), according
to the manufacturer’s instructions. RNA was quantified by
measuring the absorbance at 260 nm. The purity of the RNA
preparations was assessed by the 260/280 ratio.
cDNA was synthesized from 1𝜇g total RNA using a
reverse transcriptase (RT) system kit of Applied Biosystems
(High-Capacity cDNAReverse Transcription Kits).The reac-
tion was incubated as recommended by the manufacturer,
for 10min at 25∘C, followed by 120min at 37∘C, and then for
5min at 85∘C, and finally cooled to 4∘C to collect the cDNA
and then stored at −20∘C prior to the real-time PCR assay.
The quantitative PCR was performed using the detection
system 7900HTFast Real-Time PCR System (Applied Biosys-
tems) with Maxima SYBR Green/ROX qPCR Master Mix
(2X) (Fermentas). Target and control were run in separate
wells.
Specific primers employed, sense and antisense for each
gene, respectively, were MnSOD, 5󸀠-CGT GCT CCC ACA
CAT CAA TC-3󸀠 and 5󸀠-TGA ACG TCA CCG AGG AGA
AG-3󸀠; Catalase, 5󸀠-ACG TTG GAT GGA GAA GTG CGG
AGA TTC AAC-3󸀠 and 5󸀠-ACG TTG GAT GTT CAC ATA
GAA TGC CCG CAC-3󸀠; and GAPDH, 5󸀠-CCT GGA GAA
ACC TGC CAA GTA TG-3󸀠 and 5󸀠-GGT CCT CAG TGT
AGC CCA AGA TG-3󸀠. Target cDNAs were amplified in
separated tubes using the following procedure: 10min at
95∘C and then 40 cycles of denaturation at 95∘C for 15 s and
annealing and extension at 62∘C for 1min per cycle.
The standard curve method was used to evaluate the rel-
ative expression levels of catalase and MnSOD in resveratrol
pretreated MCF-7 cells. Briefly, the threshold cycle (Ct) was
determined and converted to a relative amount through the
use of a standard curve prepared from dilutions of cDNAmix
of all samples. The logarithmic formula used to transform Ct
values was
Exp =
(Ct, sample − Intercept)
Slope
. (1)
3.6. Statistical Analysis. Quantitative variables are expressed
as means and standard deviation of different experiments.
Once the normality of the variables was tested by Kolmo-
gorov-Smirnov test, the statistical analysis was performed
using the one-way analysis of variance (ANOVA) test to
check any possible statistically significant difference between
groups and the adequate post hoc tests. The level of signifi-
cance was chosen at 𝑃 < 0.01 or 𝑃 < 0.05. All analyses were
performed using SPSS statistical software version 19.0.
4. Discussion
Antioxidant supplementation is a common medical practice
among the elderly [25]. We report here that the antioxidant
effect of low nanomolar concentrations of resveratrol is
mediated via the upregulation of antioxidant gene expression,
involving activation of PTEN/Akt signaling pathway.
Numerous studies have reported the beneficial antioxi-
dant properties of resveratrol. For example, in human blood
platelets treated with peroxynitrite, resveratrol inhibited pro-
tein carbonylation and nitration, as well as lipid peroxidation
[6]. Resveratrol has also been shown to protect primary
hepatocytes in culture against oxidative stress damage by
increasing the activities of catalase, superoxide dismutase,
glutathione peroxidase, NADPH quinine oxidoreductase,
and glutathione-S-transferase [7]. In addition, resveratrol was
able to diminish oxidative stress by increasing gastrocnemius
catalase activity, MnSOD activity, and MnSOD protein con-
tent in young and old rats submitted to a 14-daymuscle disuse
by hindlimb suspension [9].
In our cellular model, resveratrol also acts as an antiox-
idant by increasing MnSOD and Cat mRNA levels, which
in turn decreases H
2
O
2
levels. This H
2
O
2
decrease is in
agreement with studies reporting the ability of resveratrol to
protect PC12 cells against H
2
O
2
-induced cytotoxicity [15, 16],
suggesting the potential capacity of resveratrol to prevent
oxidative stress-induced cell death. In this regard, we checked
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the potential antiapoptotic effect of 1 nM resveratrol onMCF-
7 cells by measuring BCL-XL levels by Western Blotting.
However, we did not find any difference in BCL-XL levels
between control and resveratrol group (data not shown),
suggesting that the antioxidant effect of such a low dose of
resveratrol does not affect apoptosis.
In any case, themechanismbywhich resveratrol can exert
its antioxidant effect has not been fully elucidated. Resveratrol
is able to act as a phytoestrogen andmimic estrogen biological
effects [26, 27]. However, it has also been shown to act as an
antagonist [28]. In fact, our first experiments aimed to check
if resveratrol was able to behave as estradiol in ourmodel sys-
tem, thus binding to estrogen receptors. However, we could
not inhibit resveratrol antioxidant effect when coincubating
cells with resveratrol and tamoxifen (an inhibitor of estrogen
receptors) (data not shown). Furthermore, resveratrol did
not activate MAPK and NF𝜅B signalling pathways, thus
suggesting that the pathway involved in the expression of
antioxidant genes is not mediated by estrogen receptors or
MAPK and NF𝜅B signalling pathways. Interestingly, these
results suggest that resveratrol antioxidant effects may not
change between men and women.
Here we show that PTEN, an antagonist to the PI3K/Akt
pathway, is involved in resveratrol antioxidant effects. Resver-
atrol increases PTEN and decreases phospho-Akt levels. In
this regard, Waite et al. observed that preincubation with
resveratrol or other phytoestrogens for 48 h had been able
to increase PTEN levels and decrease phospho-AKT levels
in MCF-7, at concentrations ranging from 0.1 nM to 1𝜇M
[17]. Wang et al. also found an increase in PTEN levels
when incubating a prostate cancer cell line with 10 𝜇M
resveratrol for 24 h [18]. Interestingly, PTENhas been recently
shown to increase the activity of antioxidant enzymes, such
as glutathione peroxidase (GPx), Cat, and MnSOD in a
lung cancer cell line [29]. This led us to hypothesize and
finally demonstrate that PTEN/Akt pathway was involved in
resveratrol antioxidant effect.
As stated before, resveratrol bioavailability is very low and
its absorption is highly variable, depending on the way it is
consumed and the kind of food ingested [12, 13]. Two of the
first human studies on the absorption and bioavailability of
resveratrol used a single oral dose treatment of 25mg [12, 13].
Despite the use of high sensitivity methods and a specific
molecular analysis, the presence of nonmetabolized resvera-
trol in circulating plasma was difficult to detect. Approximate
calculations showed maximal concentrations of <10 ng/mL
(≈40 nM), 0.5–2 hours after the oral dose. Estimates of the
plasma concentrations of resveratrol plus total metabolites
were considerably higher, around 400–500 ng/mL (≈2 𝜇M),
indicating a very low oral bioavailability of free resveratrol,
but significant one of its metabolites. Vitaglione et al. also
studied the bioavailability of resveratrol after red wine con-
sumption and found low micromolar (1–6𝜇M) or nanomo-
lar concentrations of free trans-resveratrol in plasma [11].
Thus, we chose for our experiment the lowest concentration
(1 nM) that was able to diminish hydrogen peroxide levels
(see Figure 1).This is indeed within the range of nutritionally
relevant concentrations found in plasma after moderate wine
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Figure 6: Proposedmechanism for resveratrol to upregulate antiox-
idant gene expression.
intake. Consuming normal amounts of resveratrol-rich nutri-
ents, such as grapes, peanuts, blueberries, blackberries, and
redwine [30],may result in plasma concentrations of free res-
veratrol that, as we show here, increase the expression of
antioxidant genes and thus may delay the onset of oxidative
stress-related conditions. Therefore, our results may have
practical importance.
5. Conclusions
The major conclusion of the current study is that nutri-
tionally relevant concentrations of resveratrol can decrease
oxidative stress within the cell by upregulating antioxidant
genes. As illustrated in Figure 6, resveratrol increases PTEN
levels, which in turn inhibits phosphoinositide 3-kinase
(PI3K) function, leading to a decrease in phospho-Akt levels
and, finally, to upregulation of antioxidant genes (Cat and
MnSOD). As a consequence, lower levels of hydrogen per-
oxide can be observed within the cell.
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